Hi Baldwidx
I understand that the US $22bn was referenced as the figure used for expected peak sales for 2591.
Using discounted multiple of x3 as apposed to x4.8 used for Skyclavs recent deal he came up with US$12.3bn for 2591 alone…
Then gave valuation of US $5bn -$$10bn for the company should 2591 have success in phase 2’s
Neuren - where to from here ?, page-39
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.09 |
Change
0.080(0.47%) |
Mkt cap ! $2.184B | |||
| Open | High | Low | Value | Volume |
| $17.38 | $17.54 | $16.84 | $10.33M | 602.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1361 | $17.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.22 | 1425 | 1 |
View Market Depth
| Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |